ClinCalc Pro
Menu
Catecholamine vasopressor / inotrope (dose-dependent) Pregnancy: Use only in life-threatening emergency.

Dopamine

Brand names: Dopamine Injection

Adult dose

Dose: Low: 2–4 mcg/kg/min (renal vasodilation); Medium: 5–10 mcg/kg/min (cardiac); High: 10–20+ mcg/kg/min (vasoconstriction)
Route: IV infusion (central line preferred)
Frequency: Continuous infusion, titrated
Max: 20 mcg/kg/min (standard); higher possible in extremis
'Low-dose dopamine' for renal protection is NOT evidence-based (ANZICS trial). Use for shock when both inotropy and vasopressor needed. Increasingly replaced by noradrenaline ± dobutamine. Central line preferred (peripheral extravasation causes necrosis).

Paediatric dose

Dose: 5 mcg/min/kg
Route: IV central
Frequency: Continuous infusion
Max: 20 micrograms/kg/min
Concentration: 1600 mcg/min/ml
2–20 mcg/kg/min. Weight-based calculation essential. Neonatal: 2–5 mcg/kg/min for renal and cardiac support. Weight-based drug tables (Broselow) used in paediatric emergencies.

Dose adjustments

Renal

Low-dose dopamine for renal protection is NOT recommended.

Hepatic

No specific adjustment.

Paediatric weight-based calculator

2–20 mcg/kg/min. Weight-based calculation essential. Neonatal: 2–5 mcg/kg/min for renal and cardiac support. Weight-based drug tables (Broselow) used in paediatric emergencies.

Clinical pearls

  • No role for 'renal-dose dopamine' — abandoned (ANZICS trial 2000)
  • SOAP-II: noradrenaline preferred over dopamine (fewer arrhythmias in septic shock)
  • High-dose dopamine increasingly replaced by noradrenaline + dobutamine combination
  • Peripheral extravasation: treat immediately with phentolamine 5 mg in 10 mL saline injected into affected area
  • MAOI interaction critical — check medication history

Contraindications

  • Phaeochromocytoma
  • Uncorrected tachyarrhythmias
  • Ventricular fibrillation

Side effects

  • Tachycardia and arrhythmias (more than noradrenaline)
  • Hypertension or hypotension
  • Necrosis and gangrene (peripheral extravasation)
  • Nausea and vomiting
  • Ischaemia (high doses)

Interactions

  • MAOIs — greatly increase pressor response (reduce dose to 1/10th)
  • Phenytoin — hypotension and bradycardia with IV combination
  • Halothane — cardiac arrhythmias

Monitoring

  • Cardiac rhythm (ECG)
  • BP
  • Urine output
  • Peripheral perfusion

Reference: BNFc; BNF; SOAP-II trial; ANZICS trial; Surviving Sepsis Guidelines. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.